Moreover, as evidenced from another monogenic ABC transporter disease, cystic fibrosis (caused by ABCC7/cystic fibrosis transmembrane conductance regulator) and pharmacological compounds can rescue membrane localization of pathogenic trafficking variants and transform patient care (37). This evidence concerns the gene ABCG2 and cystic fibrosis.